We previously reported that Runx2 transgenic mice under the control of the Prrx1 promoter, which directs transgene expression to the limb bud mesenchyme and cranial mesenchyme from embryonic day (E) 9.522, exhibit craniosynostosis, ectopic bone formation, and limb defects23. The gene discussed is RUNX2; the disease is craniosynostosis.